Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Senior Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 4 hours ago

With a proven track record, LaVoieHealthScience is dedicated to advancing innovations in health & science. Learn mo… https://t.co/79jhkK1THA
@LaVoieGroup

- 7 hours ago

Hacking Dermatology aims to put skin health in the spotlight by addressing some of the biggest challenges faced by… https://t.co/fgDajG5gHD
@LaVoieGroup

- 9 hours ago

RT @orphanwriter: "Think horses, not zebras" may have made sense years ago but today we know that #HCPs who fail to consider #rarediseases…
@LaVoieGroup

- 1 day ago

RT @PRDaily: Speaking with confidence in front of an audience can be learned. https://t.co/UtHMr9TZyS

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.